As the global community transitions from health emergency to ongoing disease management, there is a growing need for tests that can work with different collection methods that still meet the gold standard for quality and accuracy.
This campaign promotes the portfolio of next-generation Applied Biosystems TaqPath SARS-CoV-2 2.0 assays, which deliver trusted results and will help COVID-19 testing labs meet their evolving needs.
